Presentation TCT 2017 Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies! Presenter: John A. Bittl, Freek W.A. Verheugt, Gennaro Giustino October 30, 2017
Presentation TCT 2017 Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others) Presenter: Roxana Mehran, Robert W. Yeh, Stuart J. Pocock October 30, 2017
Presentation TCT 2014 Featured Lecture: First Presentation of the PLATO Primary PCI Subgroup Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Philippe Gabriel Steg September 14, 2014
Presentation The Efficacy of Ticagrelor Is Maintained in Women with ACS Participating in the PLATO trial Presenter: Steen Husted April 16, 2014
Presentation TCT 2013 Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial Presenter: Emmanouil Brilakis, Claes Held, Bernhard Meier, Frank Cools, Marc Claeys, Jan Cornel, Philip Aylward, Basil Lewis, Douglas Weaver, Gunnar Brandrup- Wognsen, Susanna Stevens, Lars Wallentin, Stefan James January 31, 2013
Presentation TCT 2012 Ticagrelor Update: PLATO: Recent Analyses Presenter: Robert Harrington October 24, 2012